Cargando…

Author Correction: Downregulation of CD40L–CD40 attenuates seizure susceptibility and severity of seizures

Detalles Bibliográficos
Autores principales:	Pototskiy, Esther, Vinokuroff, Katherine, Ojeda, Andrew, Major, C. Kendall, Sharma, Deepak, Anderson, Taylor, Howard, Kendall, Borenstein, Ronen, Musto, Alberto E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616935/ https://www.ncbi.nlm.nih.gov/pubmed/34824309 http://dx.doi.org/10.1038/s41598-021-02005-8

Ejemplares similares

Downregulation of CD40L–CD40 attenuates seizure susceptibility and severity of seizures
por: Pototskiy, Esther, et al.
Publicado: (2021)

CD40–CD40L in Neurological Disease
por: Ots, Heather D., et al.
Publicado: (2022)

The role of soluble CD40L in immunosuppression
por: Schlom, Jeffrey, et al.
Publicado: (2013)

Kick-starting the cancer-immunity cycle by targeting CD40
por: Ellmark, P, et al.
Publicado: (2015)

Author Correction: CD40 signal rewires fatty acid and glutamine metabolism for stimulating macrophage anti-tumorigenic functions
por: Liu, Pu-Ste, et al.
Publicado: (2023)

Understanding the influence of the tumor microenvironment on macrophage responses to CD40 agonists
por: Luheshi, Nadia, et al.
Publicado: (2014)

The CD40 rs1883832 Polymorphism Affects Sepsis Susceptibility and sCD40L Levels
por: Liu, Zuo-Liang, et al.
Publicado: (2018)

The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease
por: Bosmans, Laura A., et al.
Publicado: (2020)

Mechanisms of Nifedipine-Downregulated CD40L/sCD40L Signaling in Collagen Stimulated Human Platelets
por: Chen, Tso-Hsiao, et al.
Publicado: (2015)

Author’s correction for Euro Surveill. 2020;25(40)
Publicado: (2020)

The CD40–CD40L Dyad in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
por: Aarts, Suzanne A. B. M., et al.
Publicado: (2017)

Local immunotherapy based on agonistic CD40 antibodies effectively inhibits experimental bladder cancer
por: Sandin, Linda C, et al.
Publicado: (2014)

Anti-human CD40 monoclonal antibody therapy is potent without FcR crosslinking
por: Richman, Lee P, et al.
Publicado: (2014)

GPR40 modulates epileptic seizure and NMDA receptor function
por: Yang, Yong, et al.
Publicado: (2018)

Adipocytes in their (CD)40s
por: Bertola, Adeline, et al.
Publicado: (2023)

CD40/CD40L and Related Signaling Pathways in Cardiovascular Health and Disease—The Pros and Cons for Cardioprotection
por: Daub, Steffen, et al.
Publicado: (2020)

CD40-CD40L Interaction in Immunity Against Protozoan Infections
por: Chamekh, Mustapha
Publicado: (2007)

The Role of CD40/CD40 Ligand Interactions in Bone Marrow Granulopoiesis
por: Mavroudi, Irene, et al.
Publicado: (2011)

CD40/CD40 LIGAND INTERACTIONS IN IMMUNE RESPONSES AND PULMONARY IMMUNITY
por: KAWABE, TSUTOMU, et al.
Publicado: (2011)

Platelets as Key Factors in Inflammation: Focus on CD40L/CD40
por: Cognasse, Fabrice, et al.
Publicado: (2022)

Levels of human platelet-derived soluble CD40 ligand depend on haplotypes of CD40LG-CD40-ITGA2
por: Aloui, Chaker, et al.
Publicado: (2016)

Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis
por: Teruel, María, et al.
Publicado: (2012)

The Contribution of CD40/CD40L Axis in Inflammatory Bowel Disease: An Update
por: Senhaji, Nezha, et al.
Publicado: (2015)

CD40L membrane retention enhances the immunostimulatory effects of CD40 ligation
por: Elmetwali, Taha, et al.
Publicado: (2020)

CD40/CD40L expression and its prognostic value in cervical cancer
por: Grazia, G.A., et al.
Publicado: (2023)

RNA aptamers with specific binding affinity to CD40 (CD40Apt) represents a promising antagonist of the CD40-CD40L signaling for thyroid-associated ophthalmopathy (TAO) treatment in mouse
por: Chen, Yizhi, et al.
Publicado: (2023)

Cell-specific and divergent roles of the CD40L-CD40 axis in atherosclerotic vascular disease
por: Lacy, Michael, et al.
Publicado: (2021)

CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40
Publicado: (1993)

Expression of CD40 and CD40L in Gastric Cancer Tissue and Its Clinical Significance
por: Li, Rui, et al.
Publicado: (2009)

Expression of CD40, CD40L and IgM production in patients with ataxia-telangiectasia
por: Pereira, Camila Teles Machado, et al.
Publicado: (2015)

The association of CD40 polymorphisms with CD40 serum levels and risk of systemic lupus erythematosus
por: Chen, Jian-Ming, et al.
Publicado: (2015)

Multiple effects of CD40–CD40L axis in immunity against infection and cancer
por: Ara, Anjuman, et al.
Publicado: (2018)

Circulating CD40 and sCD40L Predict Changes in Renal Function in Subjects with Chronic Kidney Disease
por: Xie, Jeffrey X., et al.
Publicado: (2017)

A Critical Role for Cd40–Cd40 Ligand Interactions in Amplification of the Mucosal Cd8 T Cell Response
por: Lefrançois, Leo, et al.
Publicado: (1999)

Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals
Publicado: (1995)

A New Mechanism of NK Cell Cytotoxicity Activation: The CD40–CD40 Ligand Interaction
por: Carbone, Ennio, et al.
Publicado: (1997)

CD40/anti-CD40 antibody complexes which illustrate agonist and antagonist structural switches
por: Argiriadi, Maria A., et al.
Publicado: (2019)

CD40/CD40L Signaling as a Promising Therapeutic Target for the Treatment of Renal Disease
por: Zhang, Shungang, et al.
Publicado: (2020)

Involvement of CD40-CD40L and ICOS-ICOSL in the development of chronic rhinosinusitis by targeting eosinophils
por: Zhou, Aina, et al.
Publicado: (2023)

CD40 Ligand–CD40 Interaction Is an Intermediary between Inflammation and Angiogenesis in Proliferative Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e2o6tna0tco9h4q2nj5d7m9md3